Loading clinical trials...
Loading clinical trials...
A Phase I Study and Pharmacological Trial of Once Weekly Aminoflavone Prodrug (AFP464) Administered 3 Out of Every 4 Weeks in Solid Tumor Patients
Conditions
Interventions
AFP464
pharmacological study
+1 more
Locations
1
United States
Mayo Clinic
Rochester, Minnesota, United States
Start Date
July 1, 2006
Primary Completion Date
January 1, 2013
Last Updated
February 24, 2014
NCT06369285
NCT06332976
NCT06331793
NCT02122185
NCT01722851
NCT01703520
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions